Simple scale-up of recombinant antibody production using an UCOE containing vector

New Biotechnology

Volumn 29, Issue 4, 2012, Pages 477-484

  Boscolo, Sabrina ^a   Mion, Francesca ^a,b   Licciulli, Marta ^a   Macor, Paolo ^a   De Maso, Luca ^a   Brce, Martina ^a   Antoniou, Michael N ^c   Marzari, Roberto ^a   Santoro, Claudio ^d   Sblattero, Daniele ^d  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL RESEARCH; DIAGNOSTIC APPLICATIONS; ECONOMICAL PRODUCTION; MAMMALIAN CELLS; RECOMBINANT ANTIBODY PRODUCTION; SCALE-UP;

RECOMBINANT PROTEINS;

ANTIBODIES;

RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CPG ISLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; UBIQUITOUS CHROMATIN OPENING ELEMENT;

ANIMALS; ANTIBODY FORMATION; CHO CELLS; CRICETINAE; CRICETULUS; GENETIC VECTORS; RECOMBINANT FUSION PROTEINS; SINGLE-CHAIN ANTIBODIES;

MAMMALIA;

EID: 84860356388     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2011.12.005     Document Type: Article

References (30)

1. PhRMA Biotechnology Research Continues to Bolster Arsenal Against Disease with 633 Medicines in Development 2008, Available at: http://www.phrma.org/files/attachments/Biotech%202008.pdf.
2. Wang W., et al. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 2008, 84:548-558.
3. Nelson A.L., et al. Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 2010, 9:767-774.
4. Chu L., Robinson D.K. Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol. 2001, 12:180-187.
5. Hacker D.L., et al. 25 years of recombinant proteins from reactor-grown cells - where do we go from here?. Biotechnol. Adv. 2009, 27:1023-1027.
6. Butler M. Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems. Cytotechnology 2006, 50:57-76.
7. Dinnis D.M., James D.C. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?. Biotechnol. Bioeng. 2005, 91:180-189.
8. Jenkins N., et al. Getting the glycosylation right: implications for the biotechnology industry. Nat. Biotechnol. 1996, 14:975-981.
9. Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22:1393-1398.
10. Urlaub G., et al. Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 1983, 33:405-412.
11. Singh V. Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 1999, 30:149-158.
12. Zhang X., et al. Shaken helical track bioreactors: providing oxygen to high-density cultures of mammalian cells at volumes up to 1000L by surface aeration with air. Nat. Biotechnol. 2008, 25:68-75.
13. Zhang X., et al. Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1000-liter scale. Adv. Biochem. Eng. Biotechnol. 2010, 115:33-53.
14. Zhang X., et al. Hyperosmolarity enhances transient recombinant protein yield in Chinese hamster ovary cells. Biotechnol. Lett. 2010.
15. Grosjean F., et al. S-phase synchronized CHO cells show elevated transfection efficiency and expression using CaPi. Cytotechnology 2002, 38:57-62.
16. Williams S., et al. CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol. 2005, 5:17.
17. Harraghy N., et al. Sustained transgene expression using MAR elements. Curr. Gene Ther. 2008, 8:353-366.
18. Antoniou M., et al. Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 2003, 82:269-279.
19. Lindahl Allen M., Antoniou M. Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE). Epigenetics 2007, 2:227-236.
20. Zhang F., et al. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 2007, 110:1448-1457.
21. Zhang F., et al. A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol. Ther. 2010, 18:1640-1649.
22. Di Niro R., et al. Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. BMC Biotechnol. 2007, 7:46.
23. Marzari R., et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J. Immunol. 2001, 166:4170-4176.
24. Secchiero P., et al. Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. Int. J. Immunopathol. Pharmacol. 2009, 22:73-83.
25. Ziller F., et al. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59. Eur. J. Immunol. 2005, 35:2175-2183.
26. Marzari R., et al. The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies. Eur. J. Immunol. 2002, 32:2773-2782.
27. Hanke T., et al. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 1992, 73(Pt. 3):653-660.
28. Powers D.B., et al. Expression of single-chain Fv-Fc fusions in Pichia pastoris. J. Immunol. Methods 2001, 251:123-135.
29. Butler M. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl. Microbiol. Biotechnol. 2005, 68:283-291.
30. Kretzmer G. Industrial processes with animal cells. Appl. Microbiol. Biotechnol. 2002, 59:135-142.